肌筋膜疼痛和纤维肌痛患者疼痛量表的同时效度
Concurrent validity of pain scales in individuals with myofascial pain and fibromyalgia.
作者信息
Cheatham Scott W, Kolber Morey J, Mokha Monique, Hanney William J
机构信息
Director Pre-Physical Therapy Program, Division of Kinesiology and Recreation, SAC 1138, California State University Dominguez Hills, 1000 E. Victoria St. Carson, CA 90747, United States.
Nova Southeastern University Department of Physical Therapy 3200 South University Drive Ft. Lauderdale, FL 33328, United States.
出版信息
J Bodyw Mov Ther. 2018 Apr;22(2):355-360. doi: 10.1016/j.jbmt.2017.04.009. Epub 2017 Apr 27.
OBJECTIVE
Clinicians and researchers often use the numeric pain rating scale (NPRS) and visual analog scale (VAS) to measure and track pain in individuals with myofascial pain syndrome (MPS) and fibromyalgia (FM). The VAS is often used as a reference standard in chronic pain research. To date, no studies have specifically measured the concurrent validity of the NPRS and VAS in these individuals. The purpose of this investigation was to determine the concurrent validity of the NPRS when compared to the reference standard VAS in patients with MPS and FM.
METHODS
This investigation explored the concurrent validity of the NPRS and VAS in sixty participants with MPS (N = 30) and FM (N = 30). All participants underwent one day of testing using the American College of Rheumatology criteria for classifying FM. For each tender point (18-total), participants graded tenderness using the NPRS and VAS.
RESULTS
An excellent relationship was found between the NPRS and VAS for the MPS group (rho≥0.81, 95% CI 0.79-0.85, p < 0.001) and the FM group (rho ≥0.96, 95% CI 0.92-0.97, p < 0.001).
CONCLUSION
The results of this study suggest that the NPRS has good concurrent validity with the referenced standard VAS among individuals with MPS and FM.
目的
临床医生和研究人员经常使用数字疼痛评分量表（NPRS）和视觉模拟量表（VAS）来测量和跟踪肌筋膜疼痛综合征（MPS）和纤维肌痛（FM）患者的疼痛情况。VAS经常被用作慢性疼痛研究的参考标准。迄今为止，尚无研究专门测量NPRS和VAS在这些患者中的同时效度。本研究的目的是确定在MPS和FM患者中，与参考标准VAS相比，NPRS的同时效度。
方法
本研究探讨了NPRS和VAS在60名MPS患者（N = 30）和FM患者（N = 30）中的同时效度。所有参与者均按照美国风湿病学会的FM分类标准进行了一天的测试。对于每个压痛点（共18个），参与者使用NPRS和VAS对压痛程度进行评分。
结果
在MPS组（rho≥0.81，95%CI 0.79 - 0.85，p < 0.001）和FM组（rho≥0.96，95%CI 0.92 - 0.97，p < 0.001）中，发现NPRS和VAS之间存在极好的相关性。
结论
本研究结果表明，在MPS和FM患者中，NPRS与参考标准VAS具有良好的同时效度。
Zotero 插件